Tetsuo Mashima

Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.

Takashi Tsuruo, Hiroshi Sakamoto, T. Tsuruo, 2003, Cancer research.

Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs.

T. Mashima, Tetsuo Mashima, 2017, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal

Takashi Tsuruo, Naoya Fujita, Hiroshi Sakamoto, 2003, Cancer science.

Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling

Takashi Tsuruo, Kasturi Mukherjee, James Lyons-Weiler, 2005, Oncogene.

p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.

Takashi Tsuruo, Hiroshi Tomoda, Jun-ichi Hamada, 2005, Journal of the National Cancer Institute.

mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer

Yukiko Muramatsu, H. Seimiya, T. Mashima, 2017, Oncotarget.